
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
latest_posts
- 1
From a new flagship space telescope to lunar exploration, global cooperation – and competition – will make 2026 an exciting year for space - 2
Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids - 3
Mojtaba Khamenei unconscious in Qom, not actually running Iran - 4
Muslim Brotherhood stole half a billion dollars in Gaza donations, Arab sources reveal - 5
Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
Israeli archaeologists launch project to trace origins of ancient pottery
This Tiny Bright Yellow Frog Is One of the Most Toxic Animals on Earth
3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast
Promising Speculation Bearings for Portfolio Development in 2024
Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
5 Arising Professions in Environmentally friendly power
Two Passover initiatives target isolation and safety for Israel’s elderly
The Main 15 Powerful Business Heads of Today
Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny













